MCED

News

Elderly man talks to younger female nurse beside a Grail screening vehicle

Grail's multi-cancer test fluffs its lines in UK trial

Grail's Galleri blood test for cancer screening missed the mark in the much-anticipated NHS-Galleri trial, wreaking havoc with the firm's share price.

News

Grail multi-cancer test taps into Hims & Hers network

Grail has teamed up with telehealth company Hims & Hers to boost access to its recently filed Galleri blood test for cancer screening.

News

ESMO: Grail's data on cancer blood test firms up

Data from a new phase 3 trial of Grail's blood test for multiple cancers show improved efficacy and a lower rate of false alarms than a prior study.

News

Grail plans FDA filing for cancer blood test after new trial

Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.

Grail's multi-cancer test fluffs its lines in UK trial

Grail multi-cancer test taps into Hims & Hers network

ESMO: Grail's data on cancer blood test firms up

Grail plans FDA filing for cancer blood test after new trial

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Using AI-driven synthetic personas to take your insights fur...

MCED

Editor's Picks